Direct oral anticoagulants
163 results
1 - 100
Direct oral anticoagulants - Direct oral anticoagulants versus warfarin among atrial fibrillation patients with chronic kidney disease
Direct oral anticoagulants (DOACs) plus clarithromycin associated with higher risk of bleed than DOACs plus azithromycin
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism- Higher risk of bleeding events associated with concomitant use of amiodarone and direct oral anticoagulants
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Direct oral anticoagulants associated with better outcomes than warfarin in older patients with stroke and AF (PROSPER)
- Direct oral anticoagulants are noninferior to low-molecular-weight heparin to prevent recurrent VTE in adults with cancer
- Direct oral anticoagulants versus vitamin K antangonists in non-valvular atrial fibrillation
- Early initiation of direct oral anticoagulants after acute stroke with atrial fibrillation is at least as good as later initiation
- Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
- Mitral regurgitation
- Benefits/harms of novel oral anticoagulants similar in general population and the elderly
- Aortic stenosis
- Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism
- Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis
- Concomitant use of oral anticoagulants and SSRIs associated with increased risk of major bleeding
- The DOAC score determines bleeding risk for patients with atrial fibrillation who take a direct-acting oral anticoagulant
- Indications for and implementation of anticoagulant therapy in atrial fibrillation
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
- Antithrombotic agents in primary health care
- ACCP guidelines for antithrombotics in atrial fibrillation
- Elevated INR (> 1.5) at admission associated with increased mortality in hospitalized patients who use DOACs
- Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions
- Aspirin no different than rivaroxaban for prevention of VTE after TKA or THA
- For device-detected atrial fibrillation, anticoagulation decreases stroke risk (NNT = 100), increases major bleeding (NNTH = 62)
- Tranexamic acid in people on anticoagulants undergoing minor oral surgery or dental extractions
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
- Adults with atrial fibrillation who survive ICH and resume DOACs have fewer strokes but more recurrent ICH (PRESTIGE-AF)
- Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
- Heart valve operation: patient follow-up and complications
- Use of antithrombotic medications increases risk of hematuria-related complications
- No benefit to continuing perioperative oral anticoagulation for patients undergoing transcatheter aortic-valve implantation
- Resuming oral anticoagulants after a bleed is associated with fewer thrombi and deaths, but more bleeds
- Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
- Prevention of venous thromboembolism